Covered recipient · General Payments record
MISBAH UL-AHSAN QADIR
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$4,610.29
- Reported across 282 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $350.41 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $124.99 | 1 |
| PFIZER INC. | $67.46 | 4 |
| Daiichi Sankyo Inc. | $36.15 | 2 |
| Merck Sharp & Dohme Corporation | $33.11 | 2 |
| EISAI INC. | $21.61 | 1 |
| Sumitomo Pharma America, Inc. | $20.07 | 1 |
| Janssen Biotech, Inc. | $19.36 | 1 |
| Celgene Corporation | $14.18 | 1 |
| Acerta Pharma LLC | $13.48 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $13.48 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105633018 | CMS |
| Celgene Corporation | $14.18 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101121063 | CMS |
| Daiichi Sankyo Inc. | $18.00 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089471423 | CMS |
| Daiichi Sankyo Inc. | $18.15 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089471421 | CMS |
| Eisai Inc. | $21.61 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110767201 | CMS |
| Janssen Biotech, Inc. | $19.36 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078321653 | CMS |
| Merck Sharp & Dohme LLC | $19.57 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141669232 | CMS |
| Merck Sharp & Dohme LLC | $13.54 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141669234 | CMS |
| PFIZER INC. | $18.00 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131285836 | CMS |
| PFIZER INC. | $16.65 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131330231 | CMS |
| PFIZER INC. | $15.51 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131815300 | CMS |
| PFIZER INC. | $17.30 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131250024 | CMS |
| Regeneron Healthcare Solutions, Inc. | $124.99 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114141287 | CMS |
| Sumitomo Pharma America, Inc. | $20.07 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148906451 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.